Clinical Trial Update: Mitoxantrone Following Surgery in Treating Patients With Prostate Cancer at High Risk for Recurrence [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating mitoxantrone after surgery in high-risk prostate cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Mitoxantrone (mitoxantrone)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Prostate Cancer | Phase 2 | Status: WITHDRAWN